Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin

Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin

Propose: Total hip arthroplasty (THA) is associated with a significant risk of venous thromboembolism (VTE). Different thromboprophylaxis strategies have been used to prevent VTE. The primary aim of this study was to report the incidence of VTE and compare the efficacy and safety of rivaroxaban to e...

Full description

Bibliographic Details
Main Authors:	Wael A. Rahman, Gamal H Habsa, Omar A. Al-Mohrej, Mohammed Hammad, Naser M. Selim, Akram Hammad
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-07-01
Series:	Journal of Orthopaedic Surgery
Online Access:	https://doi.org/10.1177/2309499020938865

Similar Items

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
by: Necati Çiçek, et al.
Published: (2021-01-01)

The influence of enoxaparin or rivaroxaban for venous thromboembolism in morbidly obese patients undergoing bariatric surgery
by: Bahareh Bayat, et al.
Published: (2022-10-01)

COST- EFFECTIVENESS ANALYSIS OF APIXABANO VS. ENOXAPARIN IN THE THROMBOEMBOLISM IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER ARTHROPLASTY ELECTIVE THE HIP OR KNEE
by: Óscar Lourenço, et al.
Published: (2012-12-01)

Cost-Effectiveness of Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Adult Patients Undergoing Elective Hip or Knee Replacement Surgery in Portugal
by: José Roxo Neves, et al.
Published: (2014-01-01)

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban
by: Jose Luiz Colleoni, et al.

Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis
by: Bangsheng Hu, et al.
Published: (2021-02-01)

Increased incidence of venous thromboembolism following hip or knee arthroplasty in winter
by: Christopher Wynne Jones, et al.
Published: (2020-04-01)

Estudo comparativo entre rivaroxaban e enoxaparina na profilaxia de tromboembolismo venoso profundo em pacientes submetidos à artroplastia total do quadril Comparative study between rivaroxaban and enoxaparin in deep venous thromboembolism prophylaxis in patients submitted to total hip arthroplasty
by: Pedro Silva Kanan, et al.
Published: (2008-08-01)

Thromboprophylaxis after minimally invasive total knee arthroplasty: A comparison of rivaroxaban and enoxaparin
by: Shih-Hsiang Yen, et al.
Published: (2014-08-01)

Rivaroxaban versus enoxaparin plus clopidogrel therapy for hypertrophic cardiomyopathy-associated thromboembolism in cats
by: Kotchapol Jaturanratsamee, et al.
Published: (2024-04-01)

A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis
by: Joshua Xu, et al.
Published: (2020-01-01)

Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre
by: Anadil Faqah, et al.
Published: (2020-05-01)

Prevention of Venous Thromboembolism in Hip and Knee Arthroplasty
by: Mario Ponikvar, et al.
Published: (2010-03-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
by: Aliya Abdulla, et al.
Published: (2023-02-01)

Venous thromboembolism rates after hip and knee arthroplasty and hip fractures
by: Viswanath Mula, et al.
Published: (2020-02-01)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)

Venous thromboembolism and its prophylaxis in elective total hip arthroplasty: an international perspective.
by: Chari, A, et al.
Published: (2012)

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
by: M Stevenson, et al.
Published: (2009-10-01)

Venous Thromboembolism Prophylaxis with Rivaroxaban in Elective Foot and Ankle Surgery
by: Martin J. Wiewiorski MD, et al.
Published: (2016-08-01)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
by: Javier Trujillo‐Santos, et al.
Published: (2022-05-01)

Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial
by: Theerawit Hongnaparak, et al.
Published: (2022-11-01)

An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020
by: Daniel C. Santana, et al.
Published: (2020-08-01)

Is aspirin still relevant as a single pharmacological agent for venous thromboembolism prophylaxis post hip and knee arthroplasty surgery: A retrospective review
by: Pretorius Jacques, et al.
Published: (2022-01-01)

Pharmacoeconomic evaluation of treating acute venous thromboembolism with rivaroxaban in the inpatient setting
by: MV Avksentyeva, et al.
Published: (2014-12-01)

Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
by: Victoria Speed, et al.
Published: (2021-12-01)

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)

The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
by: Esraa Altawil, et al.
Published: (2022-10-01)

Heparin versus enoxaparine for prevention of asymptomatic deep venous thrombosis after total knee arthroplasty
by: Adnan H. Hnoosh, et al.
Published: (2013-01-01)

Bemiparin Versus Enoxaparin for Extended Thromboprophylaxis in COVID-19 Patients at High Risk of Venous Thromboembolism
by: Ahmet Can TOPÇU, et al.
Published: (2021-01-01)

Delayed surgery after hip fracture affects the incidence of venous thromboembolism
by: Takuya Taoka, et al.
Published: (2023-08-01)

Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism
by: Sara Reda, et al.
Published: (2022-05-01)

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
by: Shohei Migita, et al.
Published: (2023-08-01)

Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
by: Zhuang Liu, et al.
Published: (2023-04-01)

Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal
by: Isabel Fonseca Santos, et al.
Published: (2014-10-01)

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
by: Kwong LM
Published: (2011-07-01)

Efficacy and Safety of Rivaroxaban Versus Enoxaparin in Prevention of Recurrence of Venous Thrombo-Embolism Events in Cancer Patients: A Meta-Analysis
by: Abdul Rafeh Awan MBBS, et al.
Published: (2024-06-01)